Zusammenfassung
Patienten mit Gefäßerkrankungen stellen eine Hochrisikopopulation für operative Eingriffe dar. Auch komplexe interventionelle Prozeduren können Belastungen, etwa Beeinträchtigungen der Nierenfunktion mit sich bringen. So sollte möglichst in der Planungsphase der Eingriffe auf eine optimale Abstimmung der Medikation und Kontrolle der Risikofaktoren geachtet werden. Eine Optimierung funktioneller Einschränkungen (etwa Atemtraining bei chronisch obstruktiven Atemwegserkrankungen) ist ebenfalls in der präoperativen Phase empfohlen.
Literatur
Antoniou GA, Hajibandeh S, Hajibandeh S, Vallabhaneni SR, Brennan JA, Torella F (2015) Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery. J Vasc Surg 61(2):519–532
Bertges DJ, Goodney PP, Zhao Y, Schanzer A, Nolan BW, Likosky DS et al (2010) The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg 52(3):674–683
Bouri S, Shun-Shin MJ, Cole GD, Mayet J, Francis DP (2014) Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery. Heart 100(6):456–464
Brady AR, Gibbs JS, Greenhalgh RM, Powell JT, Sydes MR (2005) Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41(4):602–609
Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371(9627):1839–1847
Dunn AS, Turpie AG (2003) Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 163(8):901–908
Eijgenraam P, Ten CH, Ten Cate-Hoek A (2013) Safety and efficacy of bridging with low molecular weight heparins: a systematic review and partial meta-analysis. Curr Pharm Des 19(22):4014–4023
Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B et al (2014) 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 64(22):e77–e137
Juul AB, Wetterslev J, Gluud C, Kofoed-Enevoldsen A, Jensen G, Callesen T et al (2006) Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 332(7556):1482
Kaatz S, Douketis JD, Zhou H, Gage BF, White RH (2010) Risk of stroke after surgery in patients with and without chronic atrial fibrillation. J Thromb Haemost 8(5):884–890
Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF et al (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100(10):1043–1049
Mangano DT, Layug EL, Wallace A, Tateo I (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335(23):1713–1720
Mantz J, Samama CM, Tubach F, Devereaux PJ, Collet JP, Albaladejo P et al (2011) Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth 107(6):899–910
Oscarsson A, Gupta A, Fredrikson M, Järhult J, Nyström M, Pettersson E et al (2010) To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 104(3):305–312
Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD et al (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341(24):1789–1794
Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G et al (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 30(22):2769–2812
Sanders RD, Nicholson A, Lewis SR, Smith AF, Alderson P (2013) Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database Syst Rev (7):CD009971
Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC (2012) Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 126(13):1630–1639
van Veen JJ, Makris M (2015) Management of perioperative antithrombotic therapy. Anaesthesia 70(Suppl 1):58–67
Wijeysundera DN, Duncan D, Nkonde-Price C, Virani SS, Washam JB, Fleischmann KE et al (2014) Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 64(22):2406–2425
Yang H, Raymer K, Butler R, Parlow J, Roberts R (2006) The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152(5):983–990
Zaugg M, Bestmann L, Wacker J, Lucchinetti E, Boltres A, Schulz C et al (2007) Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 107(1):33–44
Zou Z, Yuan HB, Yang B, Xu F, Chen XY, Liu GJ et al (2016) Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults. Cochrane Database Syst Rev (1):CD009210
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag GmbH Deutschland
About this entry
Cite this entry
Rantner, B., Debus, S. (2017). Perioperatives Management in der operativen und interventionellen Gefäßmedizin. In: Debus, E., Gross-Fengels, W. (eds) Operative und interventionelle Gefäßmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45856-3_27-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-45856-3_27-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45856-3
Online ISBN: 978-3-662-45856-3
eBook Packages: Springer Referenz Medizin